The proposed research should focus on one of these priority topic areas:
Late Spontaneous Pre-Term Birth: Focus on prevention and treatment of diseases in mom or baby leading to spontaneous premature birth. Investigations addressing all pregnancy-related disorders must have the potential to improve clinical care to prevent adverse maternal and child outcomes.
Racial Inequities as They Relate to Morbidity and Mortality Outcomes for Mothers and Babies: Focus on physical, mental, or psychological outcomes affecting the ability of mother or child to thrive and maintain health during pregnancy, intrapartum, and up to one year postpartum. Investigations may address factors contributing to racial inequities.
Cardiovascular Health Conditions Developed During Pregnancy or Exacerbated During Pregnancy: Focus on cardiovascular conditions that begin, develop, or get worse during pregnancy and how to characterize, prevent, and/or mitigate their development. Studies may investigate periods of pregnancy, intrapartum, and/or up to one year postpartum.
Maternal Stress, Its Impact on Pregnancy Outcomes, and How to Mitigate the Effects: Focus on maternal stresses, mental, psychological, or physical. March of Dimes refers to these as Social Determinants and Drivers of Health studies. Applications in this area should have potential to impact achieving maternal and child health equity.
March of Dimes invites submissions from:
- health professionals, health researchers, epidemiologists and social scientists with doctoral academic degrees, and either a faculty appointment or equivalent at academic universities, hospitals and research institutions; or
- those who are employees of small businesses, startup companies, non-profit organizations; or
- pharmaceutical companies committed to research in the area of maternal and infant health.
These applications are not limited to U.S. citizens/are open to global applicants. Applicants may not hold any other current March of Dimes grants when applying.
Award Amount: $200,000 over two years inclusive of 10% indirect costs